Curcumin–Copper Complex Nanoparticles for the Management of Triple-Negative Breast Cancer
Authors:
- Khaled GreishKhaled Greish
- Valeria PittalàValeria Pittalà
- Sebastien TaurinSTSebastien Taurin
- Safa TahaSTSafa Taha
- Fatemah BahmanFBFatemah Bahman
- Aanchal MathurAMAanchal Mathur
- Anfal JasimAJAnfal Jasim
- Fatima MohammedFMFatima Mohammed
- Ibrahim M. El-DeebIEIbrahim M. El-Deeb
- Salim FredericksSFSalim Fredericks
- Fiza Rashid-DoubellFRFiza Rashid-Doubell
Open Access
- 1 November 2018
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 8 (11) , 884
Abstract
Breast cancer is the most common cancer diagnosed among females worldwide. Although breast cancer survival has largely improved in the past 30 years, it remains highly heterogeneous in its response to treatment. Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks the expression of the estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor-2 (Her2). While TNBC may initially be responsive to chemotherapy, recurrence and subsequent high mortality rates are frequently reported. Studies have shown curcumin and its derivatives to be effective against TNBC cell lines in vitro. To improve its anti-cancer effects, we have synthesized Fe3+–curcumin (Fe–Cur3) and Cu2+–curcumin (CD) complexes and investigated them experimentally. Further, CD was encapsulated into a poly(styrene)-co-maleic acid (SMA) micelle to enhance its stability. We assessed the cytotoxicity of these formulations both in vitro and in vivo. SMA–CD demonstrated dose-dependent cytotoxicity and abolished TNBC tumor growth in vivo. The encapsulation of the curcumin–copper complex improved its anti-cancer activity without overt adverse effects in a murine model of TNBC. These results provide evidence and insights into the value of nanoformulations in enhancing drug-delivery and increasing the potential therapeutic efficacy of curcumin derivatives.Keywords
Funding Information
- Arabian Gulf University and Royal College of Surgeons in Ireland (AGU-RCSI 2016-1)
This publication has 35 references indexed in Scilit:
- Natural Products for the Management and Prevention of Breast CancerEvidence-Based Complementary and Alternative Medicine, 2018
- Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992–2013Cancer Epidemiology, Biomarkers & Prevention, 2017
- Molecular classification of breast cancer: what the pathologist needs to knowPathology, 2017
- Natural cures for breast cancer treatmentSaudi Pharmaceutical Journal, 2016
- Curcumin and cancer: barriers to obtaining a health claimNutrition Reviews, 2015
- Heterogeneity of breast cancer: etiology and clinical relevanceClinical and Translational Oncology, 2011
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesThe International Journal of Biochemistry & Cell Biology, 2009
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- Identification of a basal-like subtype of breast ductal carcinoma in situHuman Pathology, 2007